An Overview of Current Concepts Regarding the Pathogenesis and Pathophysiology of Hypertension

  • W. M. Manger
  • I. H. Page

Abstract

Although significant strides have been made in understanding the mechanisms of secondary forms of hypertension, the etiology of essential hypertension remains an enigma. The term “essential” is a misnomer since it was originally, and erroneously, believed that elevated blood pressure was “essential” to ensure adequate tissue perfusion in patients with hypertension. Since the initiating cause, or causes, of essential hypertension are not established, a more appropriate designation would be “idiopathic” hypertension. At least 90% of the hypertensive population with both systolic and diastolic pressures elevated have this latter type of hypertension.

Keywords

Dopamine Cadmium Propranolol Dium Tritium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aars H (1968) Aortic baroreceptor activity in normal hypertensive rabbits. Acta Physiol Scand 72: 298–309PubMedGoogle Scholar
  2. 2.
    Abboud FM (1974) Effects of sodium, angiotensin, and steroids on the vascular reactivity in man. Fed Proc 33: 143–149PubMedGoogle Scholar
  3. 3.
    Ahrens RA (1974) Sucrose hypertension and heart disease; an historical perspective. Am J Clin Nutr 27: 403–422PubMedGoogle Scholar
  4. 4.
    Aiken JW (1974) Effects of prostaglandin synthesis inhibitors on angiotensin tachyphylaxis in the isolated coeliac and mesenteric arteries of the rabbit. Pol J Pharmacol Pharm 26: 217–227PubMedGoogle Scholar
  5. 5.
    Aiken JW, Vane JR (1973) Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 184: 678–687PubMedGoogle Scholar
  6. 6.
    Alexandre JM, London GM, Chevillard C, Lemoire P, Safar ME, Weiss Y (1975) The meaning of dopamine-B-hydroxylase in essential hypertension. Clin Sci Mol Med 49: 573–579PubMedGoogle Scholar
  7. 7.
    Allen FM, Sherrill JW (1922) The treatment of ar-terial hypertension. J Metabol Research 2: 429–545Google Scholar
  8. 8.
    Aronow WS, Goldsmith JR, Kern JC, Cassidy J, Nelson WH, Johnson LL, Adams W (1974) Effect of smoking cigarettes on cardiovascular hemodynamics. Arch Environ Health 28: 330–332PubMedGoogle Scholar
  9. 9.
    Ashley FW Jr, Kannel WB (1974) Relation of weight change to changes in atherogenic traits: The Framingham Study. J Chron Dis 27: 103–114PubMedGoogle Scholar
  10. 10.
    Axelrod J (1963) The formation, metabolism, uptake and release of noradrenaline and adrenaline. In: Variey H, Goweniock AH (eds) Symposium on the clinical chemistry of monoamines. Elsevier, Amsterdam, pp 5–18Google Scholar
  11. 11.
    Ayman D, Goldshine AD (1940) Blood pressure de-terminations by patients with essential hypertension. I. The difference between clinic and home readings before treatment. Am J Med Sci 220: 465–474Google Scholar
  12. 12.
    Ball JH, Kaminsky NI, Hardman, JG, Broadus AE, Sutherland EW, Liddle GW (1972) Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest 51: 2124–2129PubMedGoogle Scholar
  13. 13.
    Barrientos A, Alcazar JM, Ruilope LM, Fernandez-Tresguerres J, Garcia Robles R, Jarillo MD, Rodicio JL (1978) Effects of indomethacin in essential hypertension (abstr). Internat Soc Hypertension, Fifth Scientific Meeting, p 25Google Scholar
  14. 14.
    Beevers DG, Campbell BC, Goldberg A, Moore MR, Hawthorne VM (1976) Blood-cadmium in hypertensives and normotensives. Lancet 2: 1222–1224PubMedGoogle Scholar
  15. 15.
    Beevers DG, Erskine E, Robertson M (1976) Blood-lead and hypertension. Lancet 2: 1–3PubMedGoogle Scholar
  16. 16.
    Beilin LJ, Ziakas G (1971) Vascular reactivity in post desoxycorticosterone hypertension in rats and its relation to “irreversible” hypertension in man. Clin Sci 42: 579–590Google Scholar
  17. 17.
    Bello CT, Sevy RW, Harakal C (1965) Varying hemodynamic patterns in essential hypertension. Am J Med Sci 250: 24–35PubMedGoogle Scholar
  18. 18.
    Bello CT, Sevy RW, Harakal C, Hillyer PN (1967) Relationship between clinical severity of disease and hemodynamic patterns in essential hypertension. Am J Med Sci 253: 194–208PubMedGoogle Scholar
  19. 19.
    Bengis RG, Coleman TG, Young DB, McCaa RE (1978) Long term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor. Circ Res 43 (Suppl I): 45–53Google Scholar
  20. 20.
    Bevan AT, Honour AJ, Stott FH (1969) Direct arterial pressure recording in unrestricted man. Clin Sci 36: 329–344PubMedGoogle Scholar
  21. 21.
    Bickerton RK, Buckley JP (1961) Evidence for a central mechanism in angiotensin induced hyper-tension. Proc Soc Biol Med 106: 834–836Google Scholar
  22. 22.
    Bierenbaum ML, Fleischman AI, Dunn J, Arnold J (1975) Possible toxic water factor in coronary heart-disease. Lancet 1: 1008–1010PubMedGoogle Scholar
  23. 23.
    Bing RF, Russell GI, Thurston H, Sweles JD, Leicester UK (1980) Long term angiotensin blockade in conscious hypertensive rats: comparison with unclipping. Internat Soc Hypertension, Seventh Scientific Meeting, Abstr 12Google Scholar
  24. 24.
    Birkenhäger WH, Van Es LS, Houwing A, Lamers HJ, Mulder AH (1968) Studies on the lability of hy-pertension in man. Clin Sci 35: 445–456PubMedGoogle Scholar
  25. 25.
    Birkenhäger WH, Schalekamp MHDH, Krass XH, Roisters G, Zaal GA (1972) Consecutive haemodynamic patterns in essential hypertension. Lancet 1: 560–564PubMedGoogle Scholar
  26. 26.
    Biron P, Mongeau J-G, Bertrand D (1975) Familial aggregation of blood pressure in adopted and natural children. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 397–404Google Scholar
  27. 27.
    Blaustein MP (1977) Sodium ions, calcium ions, blood pressure regulation, and hypertension: reassessment and a hypothesis. Am J Physiol 232: C165–173PubMedGoogle Scholar
  28. 28.
    Bohr DF, Berecek KH (1976) Relevance of vascular structural and smooth muscle sensitivity changes in hypertension. Aust N Z J Med 6 (Suppl 2): 26–34PubMedGoogle Scholar
  29. 29.
    Boucher R, Demassieux S, Garcia R, Genest J (1977) Tonin-angiotensin II system. Chap 6.11 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 256–260Google Scholar
  30. 30.
    Boyle E Jr (1970) Biological patterns in hypertension by race, sex, body weight, and skin color. JAMA 213: 1637–1643PubMedGoogle Scholar
  31. 31.
    Braun-Menéndez E, Fasciolo J C, Leloir L F, Munoz JM (1940) Pharmacology of hypertension. Rev Soc Argent Biol 16: 398–410Google Scholar
  32. 32.
    Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH, Bühler FR (1972) Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441–449PubMedGoogle Scholar
  33. 33.
    Brunner HR, Sealey JE, Laragh JH (1973) Renin as a risk factor in essential hypertension. Am J Med 55: 295–302PubMedGoogle Scholar
  34. 34.
    Brunner HR, Sealey JE, Laragh JH (1973) Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics. Circ Res 32 and 33 (Suppl I): 99–109Google Scholar
  35. 35.
    Bulpitt CJ, Hoifbrand BI, Dollery CT (1976) Psychological features of patients with hypertension attending hospital follow-up clinics. J Psychosom Res 20: 403–410PubMedGoogle Scholar
  36. 36.
    Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC (1980) Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302: 772–776PubMedGoogle Scholar
  37. 37.
    Carney S, Morgan T, Wilson M, Matthews G, Roberts R (1975) Sodium restriction and thiazide diuretics in the treatment of hypertension. Med J Aust 1: 803–807PubMedGoogle Scholar
  38. 38.
    Case DB, Casarella WJ, Hassar M, Laragh JH, Cannon PJ (1972) Renal circulation and renal secretion in normal and low essential hypertension. Circ 45 and 46 (Suppl II ) (abstr): 137Google Scholar
  39. 39.
    Case DB, Wallace JM, Keim HJ, Weber MA, Sealey JE, Laragh JH (1977) Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med 296: 641–646PubMedGoogle Scholar
  40. 40.
    Casell J (1974) Hypertension and cardiovascular disease in migrants: a potential source of clues? Int J Epidemiol 3: 204–205Google Scholar
  41. 41.
    Chapnick BM, Paustian PW, Klainer E, Joiner PD, Hyman AL, Kadowitz PJ (1976) Influence of prostaglandins E, A and F on vasoconstrictor responses to norepinephrine, renal nerve stimulation and angiotensin in the feline kidney. J Pharmacol Exp Ther 916: 44–52Google Scholar
  42. 42.
    Chapnick BM, Paustian PW, Feigen LP, Joiner PD, Hyman AL, Kadowitz PJ (1977) Influence of inhibitors of prostaglandin synthesis on renal vascular resistance and on renal vascular responses to vasopressor and vasodilator agents in the cat. Circ Res 40: 348–354PubMedGoogle Scholar
  43. 43.
    Chernova NA, Nekrosova AA (1971) Urinary kallikrein in hypertensive vascular disease and renovascular hypertension (in Russian). Kardiologiia 11: 84–89PubMedGoogle Scholar
  44. 44.
    Chiang BN, Perlman LV, Epstein FH (1969) Overweight and hypertension. A review. Circulation 39: 403–421Google Scholar
  45. 45.
    Christensen MS, Christensen NJ (1972) Plasma catecholamines in hypertension. Scand J Clin Lab Invest 30: 169–173PubMedGoogle Scholar
  46. 46.
    Cobb S, Rose RM (1973) Hypertension, peptic ulcer, and diabetes in air traffic controllers. JAMA 244: 489–492Google Scholar
  47. 47.
    Coleman TG, Guyton AC (1969) Hypertension caused by salt loading in the dog III. Onset transients of cardiac output and other circulatory variables. Circ Res 25: 153–160PubMedGoogle Scholar
  48. 48.
    Conway J (1963) A vascular abnormality in hypertension. A study of blood flow in the forearm. Circulation 27: 520–529PubMedGoogle Scholar
  49. 49.
    Corcoran AC, Taylor RD, Page IH (1951) Controlled observations on the effect of low sodium dietotherapy in essential hypertension. Circulation 3: 1–16PubMedGoogle Scholar
  50. 50.
    Court JM, Hill GJ, Dunlop M, Boulton TJC (1974) Hypertension in childhood obesity. Aust Paediat J 10: 286–300Google Scholar
  51. 51.
    Cowley AW Jr, McCaa RE (1976) Acute and chronic dose-response relationships for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake. Circ Res 39: 788–797PubMedGoogle Scholar
  52. 52.
    Croxatto HR, Albertini R, Corthorn J, Rosas R (1977) Kallikrein and kinins in hypertension. Chap 8.1 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 364–373Google Scholar
  53. 53.
    Cryer PE, Haymond MW, Santiago JV, Shah SD (1976) Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 295: 573–577PubMedGoogle Scholar
  54. 54.
    Crysant SG, Walsh GM, Kem DC, Fröhlich ED (1979) Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats. Kidney International 15: 33–37Google Scholar
  55. 55.
    Cuche J-L, Kuchel O, Barbeau A, Langlois Y, Boucher R, Genest J (1974) Autonomic nervous system and benign essential hypertension in man. 1. Usual blood pressure, catecholamines, renin, and their interrelationships. Circ Res 35: 281–289Google Scholar
  56. 56.
    Dahl LK (1972) Salt and hypertension. Am J Clin Nutr 25: 231–244PubMedGoogle Scholar
  57. 57.
    Dahl LK (1977) Salt intake and hypertension. Chap 12.2 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 548–559Google Scholar
  58. 58.
    Dahl LK, Heine M, Tassinari L (1962) Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194: 480–482PubMedGoogle Scholar
  59. 59.
    Dahl LK, Heine M, Tassinari L (1962) Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115: 1173–1190PubMedGoogle Scholar
  60. 60.
    Davis JO, Freeman RH (1976) Mechanisms regulating renin release. Physiological Reviews 56: 1–56PubMedGoogle Scholar
  61. 61.
    de Champlain J (1977) The sympathetic system in hypertension. Clin Endocrinol Metab 6: 633–655PubMedGoogle Scholar
  62. 62.
    de Champlain J, Krakoif LR, Axelrod J (1968) Relationship between sodium intake and norepinephrine storage during the development of experimental hypertension. Circ Res 23: 479–491Google Scholar
  63. 63.
    de Champlain J, Farley L, Cousineau D, van Amerigen M-R (1976) Circulating catecholamine levels in human and experimental hypertension. Circ Res 38: 109–114PubMedGoogle Scholar
  64. 64.
    DeQuattro V, Chan S (1972) Raised plasma-catecholamines in some patients with primary hypertension. Lancet 1: 806–809PubMedGoogle Scholar
  65. 65.
    De Simone A, Baer L (1978) Analysis of home and office blood pressures. Prev Med 7: (Abstr A-56) 60Google Scholar
  66. 66.
    Dickinson CJ, Lawrence JR (1963) A slowly developing pressor response to small concentrations of angiotensin; its bearing on pathogenesis of chronic renal hypertension. Lancet 1: 1354–1356PubMedGoogle Scholar
  67. 67.
    Doyle AE (1977) Sympathetic nervous activity. In: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanisms, diagnosis and management. HP Publishing Co., New York, pp 201–209Google Scholar
  68. 68.
    Doyle AE (1977) Renin in hypertension: diagnostic and prognostic value. Chap 19 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 709–716Google Scholar
  69. 69.
    Doyle AE, Black H (1955) Reactivity to pressor agents in hypertension. Circulation 12: 974–980PubMedGoogle Scholar
  70. 70.
    Doyle AE, Fraser JRE (1961) Essential hypertension and inheritance of vascular reactivity. Lancet 2: 509–511PubMedGoogle Scholar
  71. 71.
    Doyle AE, Fraser JRE (1961) Vascular reactivity in hypertension. Circ Res 9: 755–758PubMedGoogle Scholar
  72. 72.
    Doyle AE, Jerums G, Johnston CI, Louis WJ (1973) Plasma renin levels and vascular complications in hypertension. Br Med J 2: 206–207PubMedGoogle Scholar
  73. 73.
    Dustan HP, Tarazi RC, Fröhlich ED (1970) Functional correlates of plasma renin activity in hypertensive patients. Circulation 41: 555–567PubMedGoogle Scholar
  74. 74.
    Dustan HP, Tarazi RC, Bravo EL, Dart RA (1973) Plasma and extracellular fluid volume in hypertension. Circ Res 32 and 33 (Suppl I): 73–83Google Scholar
  75. 75.
    Dusting GJ, Moncada S, Vane JR (1977) Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins 13: 3–15PubMedGoogle Scholar
  76. 76.
    Dworkin BR, Filewich RJ, Miller NE, Craigmyle N (1979) Baroreceptor activation reduces reactivity to noxious stimulation: Implications for hypertension. Science 205: 1299–1301PubMedGoogle Scholar
  77. 77.
    Dyer AR, Stamler J, Shekelle RB, Schoenberger J (1976) The relationship of education to blood pressure. Findings on 40,000 employed Chicagoans. Circulation 54: 987–992PubMedGoogle Scholar
  78. 78.
    Eich RH, Peters RJ, Cuddy RP, Smulyan H, Lyons RH (1962) The hemodynamics in labile hypertension. Am Heart J 63: 188–195PubMedGoogle Scholar
  79. 79.
    Eich RH, Cuddy RP, Smulyan H, Lyons RH (1966) Hemodynamics in labile hypertension. A follow-up study. Circulation 34: 299–307PubMedGoogle Scholar
  80. 80.
    Eide I, Kolloch R, de Quattro V, Miano L, Dugger R, van der Muelen J (1979) Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension 1: 255–260Google Scholar
  81. 81.
    Elliot AH, Nuzum FR (1934) The urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 18: 462–474Google Scholar
  82. 82.
    Ellis CN, Julius S (1973) Role of central blood volume in hyperkinetic borderline hypertension. Brit Heart J 35: 450–455PubMedGoogle Scholar
  83. 83.
    Engelman K, Portnoy B, Sjoerdsma A (1970) Plasma catecholamine concentrations in patients with hypertension. Circ Res 27 (Suppl I): 141–146PubMedGoogle Scholar
  84. 84.
    Erdös EG, Oshima G (1974) The angiotensin I converting enzyme of the lung and kidney. Acta Physiol Lat Am 24: 507–511PubMedGoogle Scholar
  85. 85.
    Esler MD, Nestel PJ (1973) Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. Am J Cardiol 32: 643–649PubMedGoogle Scholar
  86. 86.
    Esler MD, Nestel PJ (1973) High catecholamine essential hypertension: clinical and physiological characteristics. Aust NZ J Med 3: 117–123Google Scholar
  87. 87.
    Esler MD, Nestel PJ (1973) Sympathetic responsiveness to head-up tilt in essential hypertension. Clin Sei 44: 213–226Google Scholar
  88. 88.
    Esler MD, Julius S, Randall OS, Ellis CN, Kashima T (1975) Relation of renin status in neurogenic vascular resistance in borderline hypertension. Am J Cardiol 36: 708–715PubMedGoogle Scholar
  89. 89.
    Esler M, Julius S, Randall O (1976) Relationship of volume factors, renin and neurogenic resistance in borderline hypertension. In: Rorive G (ed) The arterial hypertensive disease. Masson, New York, pp 231–249Google Scholar
  90. 90.
    Esler M, Zweifler A, Randall O, Julius S, Bennett J, Rydelek P (1976) Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet 2: 115–118PubMedGoogle Scholar
  91. 91.
    Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, de Quattro V (1977) Mild high renin essential hypertension. N Engl J Med 296: 405–411Google Scholar
  92. 92.
    Fasciolo JC, Houssay BA, Taquini AC (1938) The blood-pressure raising secretion of the ischaemic kidney. J Physiol (Lond) 94: 281–293Google Scholar
  93. 93.
    Feinlieb M (1977) Genetics and familial aggregation of blood pressure. Chap 4 In: Onesti G, Klimt CR (eds) Hypertension: determinants, complications, and intervention. The 5th Hahnemann international symposium on hypertension. Grune and Stratton, New York, pp 35–48Google Scholar
  94. 94.
    Feinlieb M, Garrison R, Borhani N, Rosenman R, Christian J (1975) Studies of hypertension in twins. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 3–17Google Scholar
  95. 95.
    Ferrario CM, Gildenberg PL, McCubbin JW (1972) Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res 30: 257–262PubMedGoogle Scholar
  96. 96.
    Fitzsimons JT, Simons BJ (1969) The effect on drinking in the rat of intravenous infusion of angiotensin, given alone or in combination with other stimuli of thirst. J Physiol 203: 45–57PubMedGoogle Scholar
  97. 97.
    Folkow B (1971) The haemodynamic consequences of adaptive structural changes of the resistance of vessels in hypertension. Clin Sei 41: 1–12Google Scholar
  98. 98.
    Folkow B (1975) Vascular changes in hypertension: Review and recent animal studies. In: Berglund C, Hanson L, Werkö L (eds) Pathophysiology and management of arterial hypertension. Lindgren A and Söner AB, Mölndal, Sweden, pp 95–113Google Scholar
  99. 99.
    Forsyth RP (1969) Blood pressure responses to long- term avoidance schedules in the restrained Rhesus monkey. Psychosomatic Med 31: 300–309Google Scholar
  100. 100.
    Fouard FM, Tarazi RC, Dustan HP, Bravo EL (1976) Hemodynamics of essential hypertension in adolescents (abstr). Circulation 54 (Suppl II): 24Google Scholar
  101. 101.
    Franco-Morcelli R, Elghozi JL, Joly E, di Giuilio S, Meyer P (1977) Increased plasma adrenaline concentrations in benign essential hypertension. Brit Med J 2: 1251–1254Google Scholar
  102. 102.
    Franco-Morcelli R, Baudouin-Legros M, de Men- donca M, Guicheney P, Meyer P (1978) Plasma catecholamines in essential human hypertension and in DOCA-salt hypertension in the rat. Chap 5 In: Birkenhäger WH, Falke HE (eds) Circulating catecholamines and blood pressure. Bunge Scientific Publications, Utrecht, pp 27–38Google Scholar
  103. 103.
    Freeman RH, Davis JO, Lohmeier TE (1975) Des-1- asp-angiotensin II. Possible intrarenal role in homeostasis in the dog. Circ Res 37: 30–34PubMedGoogle Scholar
  104. 104.
    Friedman MJ, Bennett PL (1977) Depression and hypertension. Psychosom Med 39: 134–142PubMedGoogle Scholar
  105. 105.
    Friedman R, Dahl LK (1975) The effect of chronic conflict on the blood pressure of rats with a genetic susceptibility to experimental hypertension. Psychosom Med 37: 402–416PubMedGoogle Scholar
  106. 106.
    Friedman R, Iwai J (1976) Genetic predisposition and stress-induced hypertension. Science 193: 161–162PubMedGoogle Scholar
  107. 107.
    Friedman SM, Friedman CL (1976) Cell permeability, sodium transport and the hypertensive process in the rat. Circ Res 39: 433–441PubMedGoogle Scholar
  108. 108.
    Fröhlich ED, Tarazi RC, Dustan HP (1969) Hyperdynamic β-adrenergic circulatory state. Arch Int Med 123: 1–7Google Scholar
  109. 109.
    Fröhlich ED, Kozul VJ, Tarazi RC, Dustan HP (1970) Physiological comparison of labile and essential hypertension. Circ Res 27 (Suppl I): 55–63PubMedGoogle Scholar
  110. 110.
    Garay RP, Meyer P (1979) A new test showing abnormal net NA+ and K+ fluxes in erythrocytes of essential hypertensive patients. Lancet 1: 349–353PubMedGoogle Scholar
  111. 111.
    Gaskell P (1967) Digital vascular response to angiotensin II in normotensive and hypertensive subjects. Circ Res 20: 174–184PubMedGoogle Scholar
  112. 112.
    Geffen LB, Rush RA, Louis WJ, Doyle AE (1973) Plasma dopamine-β-hydroxylase and noradrenaline amounts in essential hypertension. Clin Sei 44: 617–620Google Scholar
  113. 113.
    Genest J (1977) Basic mechanisms of essential hypertension. Chap 12.3 In: Genest J, Koiw E, Kuchel O (eds) Hypertension. McGraw-Hill, New York, pp 559–566Google Scholar
  114. 114.
    Genest J, Boucher R, Kuchel O, Nowaczynski W (1973) Renin in hypertension: how important as a risk factor? Can Med Assoc J 209: 475–478Google Scholar
  115. 115.
    Gitlow SE, Mendlowitz M, Wilk EK, Wilk S, Wolf RL, Naftchi NE (1964) Plasma clearance of dl-H3- norepinephrine in normal human subjects and patients with essential hypertension. J Clin Invest 43: 2009–2015PubMedGoogle Scholar
  116. 116.
    Gitlow SE, Mendlowitz M, Bertani LM, Wilk EK, Glabman S (1969) Tritium excretion of normotensive and hypertensive subjects after administration of tritiated norepinephrine. J Lab Clin Med 73: 129–134PubMedGoogle Scholar
  117. 117.
    Gitlow SE, Dziedzic LM, Dziedzic SW, Wong BL (1976) Influence of ethanol on human catecholamine metabolism. Ann NY Acad Sci 273: 263–279PubMedGoogle Scholar
  118. 118.
    Glauser SC, Bello CT, Glauser EM (1976) Blood cadmium levels in normotensive and untreated hypertensive humans. Lancet 1: 717–718PubMedGoogle Scholar
  119. 119.
    Goldenberg M, Pines KL, Bladwin E, De F, Green DG, Roh CE (1948) The hemodynamic response of man to norepinephrine and epinephrine and its relation to the problem of hypertension. Am J Med 5: 792–806PubMedGoogle Scholar
  120. 120.
    Gorlin R (1962) The hyperkinetic heart syndrome. JAMA 182: 823–829PubMedGoogle Scholar
  121. 121.
    Gribbin B, Pickering TG, Sleight P, Peto R (1971) Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 29: 424–431PubMedGoogle Scholar
  122. 122.
    Grim CE, McDonough JR, Dahl LK, Hames CG (1970) Dietary sodium, potassium and blood pressure: 300 racial differences in Evans County, Georgia (abstr). Circulation 41 and 42 (Suppl III): 85Google Scholar
  123. 123.
    Grollman A (1953) Effect of increasing the extracellular fluid volume on the arterial blood pressure of the normal, hypertensive and nephrectomized dog. Am J Physiol 173: 364–370PubMedGoogle Scholar
  124. 124.
    Grollman A, Williams JR Jr, Harrison TR (1940) The preparation of renal extracts capable of reducing the blood pressure of animals with experimental renal hypertension. J Biol Chem 134: 115–121Google Scholar
  125. 125.
    Gulati SC, Adlin EV, Biddle CM, Marks AD Chan-nick BJ (1973) The occurrence of vascular complications of low renin hypertension. Ann Intern Med 78: 828Google Scholar
  126. 126.
    Guyton AC, Coleman TG (1969) Quantitative analysis of the pathophysiology of hypertension. Circ Res 24 (Suppl I):l–19Google Scholar
  127. 127.
    Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD Jr, Norman RA Jr (1973) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. In: Laragh JH (ed) Hypertension manual. Dun-Donnelley, New York, pp 111–134Google Scholar
  128. 128.
    Haddy F, Pamnani M, Clough D (1978) Review: The sodium-potassium pump in volume expanded hypertension. Clin Exp Hypertension 1: 295–336Google Scholar
  129. 129.
    Haddy FJ, Pamnani MB, Clough DL (1979) Mini-review: humoral factors and the sodium-potassium pump in volume expanded hypertension. Life Sciences 24: 2105–2118PubMedGoogle Scholar
  130. 130.
    Hallback M, Folkow B (1974) Cardiovascular responses to acute mental “stress” in spontaneously hypertensive rats. Acta Physiol Scand 90: 684–698PubMedGoogle Scholar
  131. 131.
    Hamilton JG, Grollman A (1958) The preparation of renal extracts effective in reducing blood pressure in experimental hypertension. J Biol Chem 233: 528–529PubMedGoogle Scholar
  132. 132.
    Harburg E, Erfurt JC, Chape C, Hauenstein LS, Schull WJ, Schork MA (1973) Socioecological stressor areas and black-white blood pressure: Detroit. J Chron Dis 26: 595–611PubMedGoogle Scholar
  133. 133.
    Harris AH, Gilliam WJ, Findley JD, Brady JV (1973) Instrumental conditioning of large-magnitude, daily, 12-hour blood pressure elevations in the baboon. Science 182: 175–177PubMedGoogle Scholar
  134. 134.
    Harris GS (1970) A relationship among arterial wall acid mucopolysaccharides, cation binding, and arterial reactivity. Circ Res 26 and 27 (Suppl II): 91Google Scholar
  135. 135.
    Harris GS (1975) Relationship between body sodium and arterial pressure. Clin Exp Pharmacol Physiol (Suppl 2 ): 123–126Google Scholar
  136. 136.
    Hedqvist P (1970) Studies on the effect of prostaglandins El and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta Physiol Scand (Suppl) 345: 1–40Google Scholar
  137. 137.
    Heinemann HO, Lee JB (1976) Prostaglandins and blood pressure control. Am J Med 61: 681–695PubMedGoogle Scholar
  138. 138.
    Hennekens CH, Jesse MJ, Klein BE, Gourlag JE, Blumenthal S (1976) Sibling aggregation of blood pressure: nature or nurture? Prev Med 5 (l): 60–62PubMedGoogle Scholar
  139. 139.
    Henry DP, Friedrich CL, Weinberger MH, Feinberg NS, Grim CE (1980) Norepinephrine in urine and plasma following provocative maneuvers in normal and hypertensive subjects. Hypertension 2: 20–28PubMedGoogle Scholar
  140. 140.
    Henry JP, Stephens PM (1977) Stress, health, and the social environment. A sociobiologic approach to medicine. Springer-Verlag, New York, p 282Google Scholar
  141. 141.
    Henry JP, Stephens PM, Santistenban GA (1975) A model of psychosocial hypertension showing reversibility and progression of cardiovascular complications. Circ Res 36: 156–164PubMedGoogle Scholar
  142. 142.
    Hickler RB, Lauler DP, Saravis CA, Vagnucci AI, Steiner G, Thorn GW (1964) Vasodepressor lipid from the renal medulla. Can Med Assoc J 90: 280–287PubMedGoogle Scholar
  143. 143.
    Hines EA (1940) The significance of vascular hyper- reaction as measured by the cold pressor test. Am Heart J 19: 408–416Google Scholar
  144. 144.
    Hines EA (1951) Vascular reactivity and hypertensive disease. In: Bell ET (ed) Hypertension. University of Minnesota Press, Minneapolis, pp 331–341Google Scholar
  145. 145.
    Hong Tai Eng FW, Huber-Smith M, McCann DS (1980) The role of sympathetic activity in normal renin essential hypertension. Hypertension 2: 14–19Google Scholar
  146. 146.
    Horwitz D, Alexander RW, Lovenberg W, Reiser HR (1973) Human serum dopamine-β-hydroxylase. Relationship to hypertension and sympathetic activity. Circ Res 32: 594–599PubMedGoogle Scholar
  147. 147.
    Horwitz D, Clineschmidt BV, Van Buren JM, Ommaya AK (1974) Temporal arteries from hypertensive and normotensive man. Circ Res 34 and 35 (Suppl I): 109–122Google Scholar
  148. 148.
    Ibrahim MM, Tarazi RC, Dustan HP, Bravo EL (1974) Cardiovascular factor in essential hypertension. Am Heart J 88: 724–732PubMedGoogle Scholar
  149. 149.
    Ibrahim MM, Tarazi RC, Dustan HP, Bravo EL, Gifford RW Jr (1975) Hyperkinetic heart in severe hypertension: A separate clinical hemodynamic entity. Am J Cardiol 35: 667–674PubMedGoogle Scholar
  150. 150.
    Iversen LL (1975) Uptake of circulating catechol-amines in tissues. In: Blaschko H, Sayers G, Smith DA (eds) Adrenal gland. Handbook of physiology, vol VI, sect 7, Endocrinology. Am Physiol Soc, Washington DC, pp 713–722Google Scholar
  151. 151.
    Iwai J, Knudsen KD, Dahl LK, Heine M, Leitl G (1969) Genetic influence on the development of renal hypertension in parabiotic rats. Evidence for a humoral factor. J Exp Med 129: 507–522PubMedGoogle Scholar
  152. 152.
    Johnson AL, Cornoni JC, Cassel JC, Tyroler HA, Heyden S, Hames CG (1975) Influence of race, sex and weight on blood pressure behavior in young adults. Am J Cardiol 35: 523–530PubMedGoogle Scholar
  153. 153.
    Johnston CI, Mendelsohn FAD, Doyle AE (1972) Metabolism of angiotensin II in sodium depletion and hypertension in humans. Circ Res 30 and 31 (Suppl II): 203–213Google Scholar
  154. 154.
    Jonsson A, Hansson L (1977) Prolonged exposure to a stressful stimulus (noise) as a cause of raised blood pressure in man. Lancet 1: 86–87Google Scholar
  155. 155.
    Julius S, Conway J (1968) Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 38: 282–288PubMedGoogle Scholar
  156. 156.
    Julius S, Esler M (1975) Autonomic nervous and cardiovascular regulation in borderline hypertension. Am J Cardiol 36: 685–696PubMedGoogle Scholar
  157. 157.
    Julius S, Ellis CN, Pascual AV, Matice M, Hansson L, Hunyor SN, Sandler LN (1974) Home blood pressure determination. Value in borderline (“labile”) hypertension. JAMA 229: 663–670PubMedGoogle Scholar
  158. 158.
    Julius S, Esler M, Randall O (1974) Neurogenic borderline hypertension (abstr). Circulation 50 (Suppl III): 107Google Scholar
  159. 159.
    Julius S, Esler MD, Randall OS (1975) Role of the autonomic nervous system in mild human hypertension. Clin Sci Mol Med 48 (Suppl): 243s–252sGoogle Scholar
  160. 160.
    Julius S, Randall OS, Esler MD, Kasima T, Ellis C, Bennett J (1975) Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ Res 36 and 37 (Suppl I): 199–207Google Scholar
  161. 161.
    Kannel WB (1971) Current state of the epidemiology of brain infarction associated with occlusive arterial disease. Stroke 2: 295–318PubMedGoogle Scholar
  162. 162.
    Kannel WB, Sorlie P (1975) Hypertension in Framingham. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 553–587Google Scholar
  163. 163.
    Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamara PM (1967) The relation of adiposity to blood pressure and development of hypertension. Ann Intern Med 67: 48–59PubMedGoogle Scholar
  164. 164.
    Kannel WB, Castelli WP, McNamara PM, Sorlie P (1969) Some factors affecting morbidity and mortality in hypertension. The Framingham Study. Mid-bank Memorial Fund Q 47, no 3, part 2: 116–142Google Scholar
  165. 165.
    Kannel WB, Gordon T, Schwartz MJ (1971) Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham Study. Am J Cardiol 27: 335–346Google Scholar
  166. 166.
    Kaplan NM (1975) The prognostic implications of plasma renin in essential hypertension. JAMA 231: 167–170PubMedGoogle Scholar
  167. 167.
    Kaplan NM (1978) Clinical hypertension, 2nd ed. Williams and Wilkins, Baltimore, 405 ppGoogle Scholar
  168. 168.
    Kaplan NM, Silah JG (1964) The angiotensin-infusion test. A new approach to the differential diagnosis of renovascular hypertension. N Engl J Med 271: 536–541PubMedGoogle Scholar
  169. 169.
    Kaplan NM, Silah JG (1964) The effect of angiotensin II on the blood pressure in humans with hypertensive disease. J Clin Invest 43: 659–669PubMedGoogle Scholar
  170. 170.
    Kass EH, Zinner SH, Margolius HS, Lee Y, Rosner B, Donner H (1975) Familial aggregation of blood pressure and urine kallikrein in early childhood. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 359–374Google Scholar
  171. 171.
    Kempner W (1944) Treatment of kidney disease and hypertensive vascular disease with rice diet. N C Med J 5: 125–133Google Scholar
  172. 172.
    Kempner W (1948) Treatment of hypertensive vascular disease with the rice diet. Am J Med 4: 545–577PubMedGoogle Scholar
  173. 173.
    Keys A, Aravanis C, Blackburn H, van Buchem FS P, Buzina R, Djordjevic BS, Fidanza F, Karvonen MF, Menotti A, Pudda V, Taylor HL (1972) Coronary heart disease: overweight and obesity as risk factors. Ann Intern Med 77: 15–27PubMedGoogle Scholar
  174. 174.
    Khosla MC, Page IH, Bumpus FM (1979) Interrelations between various blood pressure regulatory systems and the mosaic theory of hypertension. Biochem Pharmacol 28: 2867–2882PubMedGoogle Scholar
  175. 175.
    Kisch ES, Dluhy RG, Williams GH (1976) Enhanced aldosterone response to angiotensin II in human hypertension. Circ Res 38: 502–505PubMedGoogle Scholar
  176. 176.
    Klatsky AL, Friedman GD, Sieglaub AB, Gerard M J (1977) Alcohol consumption and blood pressure. N Engl J Med 296: 1194–1200PubMedGoogle Scholar
  177. 177.
    Kopin I J, Kaufman S, Viveros H, Jacobowitz D, Lake R, Ziegler MG, Lovenburg W, Goodwin FK (1976) Dopamine-β-hydroxylase. Basic and clinical studies. Ann Intern Med 85: 211–223Google Scholar
  178. 178.
    Korner PI, Fletcher PJ (1977) Role of the heart in causing and maintaining hypertension. Cardiovasc Med 2: 139–155Google Scholar
  179. 179.
    Kuchel O (1976) Adrenergic reactivity in low renin and normal renin essential hypertension. Circ Res 39: 289–290PubMedGoogle Scholar
  180. 180.
    Kuchel 0 (1977) Autonomic nervous system in hypertension: clinical aspects. Chap 5.3 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 93–114Google Scholar
  181. 181.
    Kuchel O (1980) In discussion. In: Hunt JC, Cooper T, Fröhlich ED, Gifford RW Jr, Kaplan NM, Laragh JH, Maxwell MH, Strong CG (eds) Dialogues in hypertension. Hypertension update: mechanisms, epidemiology, evaluation, management. Health Learning Systems, Bloomfield, NJ, pp 131–132Google Scholar
  182. 182.
    Kuchel O, Cuche JL, Barbeau A, Hamet P, Boucher R, Nowaczynski W, Genest J (1970) Low grade hypertension and β-adrenergic hyperactivity: two extreme poles of essential hypertension. Circulation 42 (Suppl III ) (abstr): 70Google Scholar
  183. 183.
    Kuchel O, Cuche JL, Hamet P, Boucher R, Barbeau A, Genest J (1972) The relationship between adrenergic nervous system and renin in labile hyperkinetic hypertension. In: Genest J, Koiw E (eds) Hypertension. Springer-Verlag, New York, pp 118–125Google Scholar
  184. 184.
    Kuchel O, Cuche JL, Hamet P, Tolis G, Masserli FH, Barbeau A, Boucher R, Genest J (1975) Labile (borderline) hypertension—new aspects of a common disorder. Angiology 26: 619–631PubMedGoogle Scholar
  185. 185.
    Kuchel O, Buu NT, Hamet P, Guthrie GP Jr, Cuche JL, Boucher R, Genest J (1977) Catecholamines, cyclic AMP and renin in two contrasting forms of essential hypertension. Contrib Nephrol 8: 27–36PubMedGoogle Scholar
  186. 186.
    Kuchel O, Buu NT, Linger T (1978) Dopamine-sodium relationship: is dopamine a part of the endogenous natriuretic system? Contrib Nephrol 13: 27–36PubMedGoogle Scholar
  187. 187.
    Kunin CM, McCormack RC (1968) An epidemiologic study of bacteriurea and blood pressure among nuns and working women. N Engl J Med 278: 635–642PubMedGoogle Scholar
  188. 188.
    Kuschke HJ (1961) Investigation about the state of excitation of the sympathetic nervous system and the adrenal medulla in cardiovascular disease. Arch Kreislaufforsch 36: 104–148PubMedGoogle Scholar
  189. 189.
    Lake CR, Ziegler MG, Coleman M, Kopin IJ (1976) Plasma norepinephrine and dopamine-beta-hydroxylase in hypertension. Fed Proc 35 (abstr 1063): 398Google Scholar
  190. 190.
    Lake CR, Ziegler MG, Kopin IJ (1976) Use of plasma norepinephrine for evaluation of sympathetic neural function in man. Life Sciences 18: 1315–1326PubMedGoogle Scholar
  191. 191.
    Lake CR, Ziegler MG, Coleman MD, Kopin IJ (1977) Age adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296: 208–209PubMedGoogle Scholar
  192. 192.
    Langford HG (1978) Salt and hypertension: discussion. In: Mild hypertension: to treat or not to treat. Ann N Y Acad Sei 304: 198–199Google Scholar
  193. 193.
    Laragh JH (1974) An approach to the classification of hypertensive states. Hosp Prac (Jan): 61–73Google Scholar
  194. 194.
    Laragh JH (1977) An approach to the classification of hypertensive states. Chap 1 In: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanism, diagnosis and management. HP Publishing Co, New York, pp 1–13Google Scholar
  195. 195.
    Laragh JH (1977) Vasoconstriction-volume analysis in treatment of hypertension. Chap 7 In: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanisms, diagnosis and management. HP Publishing Co, New York, pp 69–79Google Scholar
  196. 196.
    Lauer RM, Filer LJ, Reiter MA, Clarke WR (1977) Blood pressure, salt preference, salt threshold, and relative weight. Am J Dis Childhood 130: 493–497Google Scholar
  197. 197.
    Lazarus JM, Hampers CL, Bennett AH, Vandam LD, Merrill JP (1972) Urgent bilateral nephrectomy for severe hypertension. Ann Intern Med 76: 733–739PubMedGoogle Scholar
  198. 198.
    Lee JB (1967) Antihypertensive activity of the kidney—the renomedullary prostaglandins. N Engl J Med 277: 1073–1079PubMedGoogle Scholar
  199. 199.
    Lee JB (1974) Cardiovascular-renal effects of prostaglandins. Arch Intern Med 133: 56–76PubMedGoogle Scholar
  200. 200.
    Lee JB (1977) Prostaglandins, neutral lipids, renal interstitial cells, and hypertension. Chap 8.2 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 373–397Google Scholar
  201. 201.
    Lee JB, Hickler RB, Saravis CA, Thorn GW (1963) Sustained depressor effect of renal medullary extract in the normotensive rat. Circ Res 13: 359–366PubMedGoogle Scholar
  202. 202.
    Lee Y-H, Rosner B, Gould JB, Lowe EW, Kass EH (1976) Familial aggregation of blood pressures of newborn infants and their mothers. Pediatrics 58: 722–729PubMedGoogle Scholar
  203. 203.
    Levine LS, Lewy JE, New MI (1976) Hypertension in high school students. NY State J Med 76: 40–44Google Scholar
  204. 204.
    Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein and plasma renin activity as determinants of renal blood flow. J Clin Invest 60: 129–138PubMedGoogle Scholar
  205. 205.
    Liard J-F Tarazi RC, Ferrario CM, Manger WM (1975) Hemodynamic and humoral characteristics of hypertension induced by prolonged stellate ganglion stimulation in conscious dogs. Circ Res 36: 455–464Google Scholar
  206. 206.
    Loggie JMH (1975) Hypertension in children and adolescents. Hosp Practice 10 (6): 81–92Google Scholar
  207. 207.
    Londe S, Goldring D (1976) High blood pressure in children: problems and guidelines for evaluation and treatment. Am J Cardiol 37: 650–657PubMedGoogle Scholar
  208. 208.
    Londe S, Bourgoignie JJ, Robson AM, Goldring D (1971) Hypertension in apparently normal children. J Pediat 78: 569–577PubMedGoogle Scholar
  209. 209.
    Louis WJ, Tabei R, Spector S (1971) Effects of sodium intake and inherited hypertension in the rat. Lancet 2: 1283–1286PubMedGoogle Scholar
  210. 210.
    Louis WJ, Doyle AE, Anavekar S (1973) Plasma norepinephrine levels in essential hypertension. N Engl J Med 288: 599–601PubMedGoogle Scholar
  211. 211.
    Lowder SC, Hamet P, Liddle GW (1976) Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3’,5’-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension. Circ Res 38: 105–108PubMedGoogle Scholar
  212. 212.
    Lowenstein FW (1961) A study of blood pressure and body measurements in medical students in the Brazilian city of Belem. Cardiologia 39: 46–56PubMedGoogle Scholar
  213. 213.
    Lucas CP, Holzwarth GJ, Ocobock RW, Sozen T, Stern MP, Wood PDS, Haskell WL, Farquhar JW (1974) Disturbed relationship of plasma-renin to blood-pressure in hypertension. Lancet 2: 1337–1339PubMedGoogle Scholar
  214. 214.
    Luft F, Bloch R, Grim C, Henry D, Weinberger M (1978) Sympathetic nervous system activity (SNSA) and salt balance. J Clin Res 26: 365AGoogle Scholar
  215. 215.
    Lundgren Y (1974) Regression of structural cardio-vascular changes after reversal of experimental renal hypertension in rats. Acta Physiol Scand 91: 275–285PubMedGoogle Scholar
  216. 216.
    Lund-Johansen P (1968) Hemodynamics in early essential hypertension. Acta Med Scand 183 (Suppl 482): 1–101Google Scholar
  217. 217.
    Lund-Johansen P (1978) Spontaneous changes in central hemodynamics in essential hypertension: a 10-year follow-up study. In: Onesti G, Klimpt R, Schaefer RJ (eds) Hypertension: determinants, complications and intervention. Grune and Stratton. New York, pp 201–209Google Scholar
  218. 218.
    Malik KU, Nasjletti A (1976) Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res 38: 26–30PubMedGoogle Scholar
  219. 219.
    Manger WM, Gifford RW Jr (1977) Pheochromocytoma. Springer-Verlag, New York, p 3Google Scholar
  220. 220.
    Manger WM, von Estorff I, Davis S, Chu D, Wakim K, Dufton S (1975) Inadequacy of plasma catechol-amines as an index of adrenergic activity. Fed Proc 34 (abstr 2853): 723Google Scholar
  221. 221.
    Manger WM, Fröhlich ED, Gifford RW, Dustan HP (1976) Norepinephrine infusion in normal subjects and patients with essential or renal hypertension: effect on blood pressure, heart rate, and plasma catecholamine concentrations. J Clin Pharmacol 16: 129–141PubMedGoogle Scholar
  222. 222.
    Manger WM, van Praag D, Weiss RJ, Hart CJ, Hülse M, Rock TW, Färber SJ (1976) Effect of transplanting renomedullary tissue into spontaneously hypertensive rats (SHR). Fed Proc 35 (abstr 1931): 556Google Scholar
  223. 223.
    Manthorpe T (1973) The effect on renal hypertension of subcutaneous isotransplantation of renal medulla from normal or hypertensive rats. Acta Pathol Microbiol Scand 8lA:725–733Google Scholar
  224. 224.
    Margolius HS, Geller R, Pisano JJ, Sjoerdsma A (1971) Altered urinary kallikrein excretion in human hypertension. Lancet 2: 1063–1065Google Scholar
  225. 225.
    Margolius H, Horwitz D, Pisano J, Reiser H (1973) Urinary kallikrein and human hypertension: effects of salt and mineralocorticoids. Clin Res 21 (abstr): 699Google Scholar
  226. 226.
    Margolius HS, Horwitz D, Pisano JJ, Reiser HR (1974) Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res 35: 820–825PubMedGoogle Scholar
  227. 227.
    Margolius HS, Horwitz D, Pisano JJ, Reiser HR (1976) Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease. Fed Proc 35: 203–206PubMedGoogle Scholar
  228. 228.
    Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE (1974) Effects of high and low sodium in-take on blood pressure reactivity in borderline hypertensive subjects. Circulation 50 (Suppl III): 107Google Scholar
  229. 229.
    Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE, Heistad DD (1975) Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension. A preliminary report. Clin Res 36 and 37 (Suppl I): 194–198Google Scholar
  230. 230.
    Mathews JD (1976) Alcohol usage as a possible explanation for socio-economic and occupational differentials in mortality from hypertension and coronary heart disease in England and Wales. Aust NZ J Med 6: 393–397Google Scholar
  231. 231.
    Maxwell MH (1975) Cooperative study of renovascular hypertension: current status. Kidney Int 8 (Suppl 5): 153 - 160Google Scholar
  232. 232.
    McCubbin JW, Page IH (1963) Renal pressor system and neurogenic control of arterial blood pressure. Circ Res 12: 553–559Google Scholar
  233. 233.
    McCubbin JW, Green JH, Page IH (1956) Baroreceptor function in chronic renal hypertension. Circ Res 4: 205–210PubMedGoogle Scholar
  234. 234.
    McCubbin JW, De Moura RJ, Page IH, Olmsted F (1965) Arterial hypertension elicited by subpressor amounts of angiotensin. Science 149: 1394–1395PubMedGoogle Scholar
  235. 235.
    McGiff JC, Nasjletti A (1976) Kinins, renal function and blood pressure regulation. Fed Proc 35: 172–174PubMedGoogle Scholar
  236. 236.
    McGiff JC, Crowshaw K, Terragno NA, Lonigro AJ (1970) Renal prostaglandins: possible regulators of the renal actions of pressor hormones. Nature 227: 1255–1257PubMedGoogle Scholar
  237. 237.
    McGiff JC, Crowshaw K, Itskovitz HD (1974) Prostaglandins and renal function. Fed Proc 33: 39–47PubMedGoogle Scholar
  238. 238.
    Mendlowitz M (1973) Vascular reactivity in systemic arterial hypertension. Am Heart J 85: 252–259PubMedGoogle Scholar
  239. 239.
    Mendlowitz M U979) The many faces of hypertension: environmental and genetic theories. Clin Exp Hypertension 1:423–447Google Scholar
  240. 240.
    Mendlowitz M, Naftchi N (1958) Work of digital vasoconstriction produced by infused norepinephrine in primary hypertension. J Appl Physiol 13: 247–256PubMedGoogle Scholar
  241. 241.
    Mendlowitz M, Wolf RL, Gitlow SE (1970) Catecholamine metabolism in essential hypertension. Am Heart J 79: 401–407PubMedGoogle Scholar
  242. 242.
    Meneely GR (1978) Salt and hypertension: general discussion. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sei 304: 201Google Scholar
  243. 243.
    Meneely GR, Battarbee HD (1976) High sodium-low potassium environment and hypertension. Am J Cardiol 38: 768–785PubMedGoogle Scholar
  244. 244.
    Meneely GR, Tucker RG, Darby WJ, Auerbach SH (1953) Chronic sodium chloride toxicity in the albino rat. II. Occurrence of hypertension and a syndrome of edema and renal failure. J Exp Med 98: 71–80PubMedGoogle Scholar
  245. 245.
    Mersey JH, Williams GH, Hollenberg NK, Dluhy R G (1977) Relationship between aldosterone and bradykinin. Circ Res 40 and 41 (Suppl I): 84–88Google Scholar
  246. 246.
    Messerli FH, Genest J, Nowaczynski W, Kuchel O, Honda M, Latour Y, Dumont G (1975) Splanchnic blood flow in essential hypertension and in hypertensive patients with renal artery stenosis. Circulation 51: 1114–1119PubMedGoogle Scholar
  247. 247.
    Messerli FH, Kuchel O, Hamet P, Tolis G, Guthries, GP Jr, Fraysee J, Nowaczynski W, Genest J (1976) Plasma cyclic adenosine 3’,5’-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension. Circ Res 38 (Suppl II): 42–47PubMedGoogle Scholar
  248. 248.
    Miall WE (1978) Genetic considerations concerning hypertension. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sei 304: 18–27Google Scholar
  249. 249.
    Miall WE, Chinn S (1973) Blood pressure and aging; results of a 15–17 year follow-up study in South Wales. Clin Sei Mol Med 45 (Suppl I): 23–33Google Scholar
  250. 250.
    Michelakis AM, Caudle J, Liddle GW (1969) In vitro stimulation of renin production by epinephrine, norepinephrine and cyclic AMP. Proc Soc Exp Biol Med 130: 748–753Google Scholar
  251. 251.
    Mitchell SC, Blount SG Jr, Blumenthal S, Hoffman JIE, Jesse MJ, Lauer RM, Weidman WH (1975) The pediatrician and hypertension. Pediatrics 56: 3–5PubMedGoogle Scholar
  252. 252.
    Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC (1977) Renin-aldosterone profiling in hypertension. Ann Intern Med 87: 596–612PubMedGoogle Scholar
  253. 253.
    Molzahn M, Dissmann Th, Götzen R, Lohmann FW (1971) The effects of acute and chronic diminution of cardiac output on blood pressure in early hypertension. Hemodynamic alterations after β-receptor blockade. Klin Wochenschr 49: 476–484PubMedGoogle Scholar
  254. 254.
    Molzahn M, Dissmann Th, Halim S, Lohmann FW, Oelkers W (1972) Orthostatic changes of heamodynamics, renal function, plasma catecholamines and plasma renin concentration in normal and hypertensive man. Clin Sei 42: 209–222Google Scholar
  255. 255.
    Morton WE, Knudsen JC (1975) Correlates of hypertension among young men. Prev Med 4: 258–267PubMedGoogle Scholar
  256. 256.
    Mroczek WJ, Finnerty FA, Catt KJ (1973) Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension. Lancet 2: 464–468PubMedGoogle Scholar
  257. 257.
    Muehrcke RC, Mandal AK, Volini FI (1970) A pathophysiological review of the renal medullary interstitial cells and their relationship to hypertension. Circ Res 26 and 27 (Suppl I): 109–119Google Scholar
  258. 258.
    Muirhead EE (1977) The antihypertensive function of the renal medulla. Chap 14 In: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanisms, diagnosis and management. HP Publishing Co, New York, pp 145–156Google Scholar
  259. 259.
    Muirhead EE (1981) Antihypertensive functions of the kidney. In: The third Arthur C Corcoran memorial lecture. Hypertension 2: 444–464Google Scholar
  260. 260.
    Muirhead EE, Jones J, Graham P (1953) Hypertension in bilaterally nephrectomized dogs in the absence of exogenous sodium excess. Arch Pathol 56: 286–292Google Scholar
  261. 261.
    Muirhead EE, Germain G, Leach B, Pitcock JA, Stephenson P, Brooks B, Brosius WL, Daniels EG, Hinman JW (1972) Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture. Circ Res 30 and 31 (Suppl II): 161–172Google Scholar
  262. 262.
    Murray RH, Luft FC, Bloch R, Weyman AE (1978) Blood pressure responses to extremes of sodium in-take in normal man. Proc Soc Exp Biol Med 159: 432–436PubMedGoogle Scholar
  263. 263.
    Naditch MP (1974) Locus of control, relative discontent and hypertension. Soc Psych 9: 111–117Google Scholar
  264. 264.
    Nasjletti A, McGiif JC, Colina-Chourio J (1978) Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat: influence of mineralocorticoids. Circ Res 43: 799–807PubMedGoogle Scholar
  265. 265.
    Nestel PJ (1969) Blood pressure and catecholamine excretion after mental stress in labile hypertension. Lancet 1: 692–694PubMedGoogle Scholar
  266. 266.
    Nestel PJ, Doyle AE (1968) The excretion of free noradrenaline and adrenaline by healthy young subjects and by patients with essential hypertension. Aust Ann Med 17: 295–299PubMedGoogle Scholar
  267. 267.
    Nicholls MG, Kiowski W, Zweifler AJ, Julius S, Schork MA, Greenhouse J (1980) Plasma norepinephrine variations with dietary sodium intake. Hypertension 2: 29–32PubMedGoogle Scholar
  268. 268.
    Nies AS (1975) Adverse reactions and interactions limiting the use of antihypertensive drugs. Am J Med 58: 495–503PubMedGoogle Scholar
  269. 269.
    Noth RH, Mulrow PJ (1976) Serum dopamine-β-hydroxylase as an index of sympathetic nervous system activity in man. Circ Res 38: 2–5Google Scholar
  270. 270.
    Nustad K, Vaaje K, Pierce JV (1975) Synthesis of kallikrein by rat kidney slices. Brit J Pharmacol 53: 229–234Google Scholar
  271. 271.
    Gates JA, Robertson D (1980) The sympathetic ner-vous system. In: Hunt JC, Cooper T, Fröhlich ED, Giiford RW, Kaplan NM, Laragh JH, Maxwell MH, Strong CG (eds) Hypertension update: mechanisms, epidemiology, evaluation, management. Health Learning Systems, Bloomfield, NJ, pp 135–142Google Scholar
  272. 272.
    Oekler SW, Schöneshöfer M, Schultze G, Brown JJ, Frazer R, Morton JJ, Lever AF, Robertson JIS (1975) Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in man. Circ Res 36 and 37 (Suppl I): 49–56Google Scholar
  273. 273.
    Oliver WJ, Cohen EL, Neel JV (1975) Blood pressure, sodium intake and sodium related hormones in the Yanomamo Indians, a “no-salt” culture. Circulation 52: 146–151PubMedGoogle Scholar
  274. 274.
    Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196: 441–444PubMedGoogle Scholar
  275. 275.
    Ostergaard K (1977) Cadmium and hypertension. Lancet 1: 677–678PubMedGoogle Scholar
  276. 276.
    Östman-Smith I (1979) Adaptive changes in the sympathetic nervous system and some effector organs of the rat following long term exercise or cold acclimation and the role of cardiac sympathetic nerves in the genesis of compensatory cardiac hypertrophy. Acta Physiol Scand 477: 1–118Google Scholar
  277. 277.
    Padfield PL, Beevers DG, Brown JJ, Davies DL, Lever AF, Robertson JIS, Schalekamp MAD, Tree M (1975) Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet 1: 548–550PubMedGoogle Scholar
  278. 278.
    Page IH (1949) Pathogenesis of arterial hypertension. JAMA 140: 451–458Google Scholar
  279. 279.
    Page IH (1976) Commentary: egregious errors in the management of hypertension. JAMA 236: 2621–2622PubMedGoogle Scholar
  280. 280.
    Page IH (1977) Some regulatory mechanisms of renovascular and essential arterial hypertension. Chap 12.5 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 576–587Google Scholar
  281. 281.
    Page IH (1979) The continuing failure to under-stand hypertension. JAMA 241: 1897–1898PubMedGoogle Scholar
  282. 282.
    Page IH, Helmer OM, Kohlstaedt KG, Fouts PJ, Kempf GF, Corcoran AC (1940) Substances in kidneys and muscles eliciting prolonged reduction of blood pressure in human and experimental hypertension. Proc Soc Exp Biol Med 43: 722–728Google Scholar
  283. 283.
    Page LB (1978) Salt and hypertension: general discussion. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sei 304: 200Google Scholar
  284. 284.
    Page LB, Damon A, Moellering RC Jr (1974) Antecedents of cardiovascular disease in six Solomon Is-land societies. Circulation 49: 1132–1146PubMedGoogle Scholar
  285. 285.
    Panisset JC, Bourdois P (1968) Effect of angiotensin on the response to noradrenaline and sympathetic nerve stimulation and on 3H-noradrenaline uptake in cat mesenteric blood vessels. Can J Physiol Pharmacol 46: 125–131PubMedGoogle Scholar
  286. 286.
    Parijs J, Joossens JV, van der Linden L, Verstreken G, Amery AKPC (1973) Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J 85: 22–34PubMedGoogle Scholar
  287. 287.
    Pedersen EB, Christensen NJ (1975) Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. Acta Med Scand 198: 373–377PubMedGoogle Scholar
  288. 288.
    Perera GA (1948) Diagnosis and natural history of hypertensive vascular disease. Am J Med 4: 416–422PubMedGoogle Scholar
  289. 289.
    Perwitt RL, Leach BE, Byers LW, Brooks B, Lands WEM, Muirhead E (1979) Antihypertensive polar renomedullary lipid, a semisynthetic vasodilator. Hypertension 1: 299–308Google Scholar
  290. 290.
    Pickering GW (1973) Hypertension: definitions, natural histories and consequences. In: Laragh JH (ed) Hypertension manual: mechanisms, methods, management. Dun-Donnelley, New York, pp 3–30Google Scholar
  291. 291.
    Pilowsky I, Spalding D, Shaw J, Korner PI (1973) Hypertension and personality. Psychosom Med 35: 50–56PubMedGoogle Scholar
  292. 292.
    Piatt R (1967) The influence of heredity. In: Stamler J, Stamler R, Pullman TN (eds) The epidemiology of hypertension. Grune and Stratton, New York, pp 9–17Google Scholar
  293. 293.
    Prior LAM, Evans JG, Harvey HPD, Davidson F, Lindsey M (1968) Sodium intake and blood pressure in two Polynesian populations. N Engl J Med 279: 515–520PubMedGoogle Scholar
  294. 294.
    Rabkin SW, Mathewson FAL, Hsu P-H (1977) Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 39: 452–458PubMedGoogle Scholar
  295. 295.
    Reid JL, Zivin JA, Kopin IJ (1975) Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res 37: 569–579PubMedGoogle Scholar
  296. 296.
    Reid JL, Jones DH, Dargie HJ (1977) Plasma noradrenaline and hypertension. Postgrad Med J 53 (Suppl 3): 40–42PubMedGoogle Scholar
  297. 297.
    Reid JL, Dean CR, Hamilton C, Watson R, Jones DH, Littler W (1978) Relationships between blood pressure, heart rate and plasma noradrenaline. In: Birkenhäger WH, Falke HE (eds) Circulating catecholamines and blood pressure. Bunge Scientific Publications, Utrecht, pp 11–16Google Scholar
  298. 298.
    Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298: 1–6PubMedGoogle Scholar
  299. 299.
    Reit E (1972) Actions of angiotensin on the adrenal medulla and autonomic ganglia. Fed Proc 31: 1338–1343PubMedGoogle Scholar
  300. 300.
    Remington RD, Lambarth B, Moser M, Hoobler SW (1960) Circulatory reactions of normotensive and hypertensive subjects and the children of normal and hypertensive parents. Am Heart J 59: 58–70PubMedGoogle Scholar
  301. 301.
    Robertson DH, Johnson GA, Brilis GM, Hill RE, Watson JT, Oates JA (1977) Salt restriction increases serum catecholamines and urinary metanephrine excretion (abstr). Fed Proc 36: 956Google Scholar
  302. 302.
    Robison GA, Butcher RW, Sutherland EW (1971) Cyclic AMP. Academic Press, New YorkGoogle Scholar
  303. 303.
    Rodicio J (1980) In discussion. In: Hunt JC, Cooper T, Fröhlich ED, Gifford RW Jr, Kaplan NM, Laragh JH, Maxell MH, Strong CG (eds) Dialogues in hypertension. Hypertension update: mechanisms, epidemiology, evaluation, management. Health Learning Systems, Bloomfield, NJ, pp 133, 134Google Scholar
  304. 304.
    Romero JC, Strong CG (1977) The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension. Circ Res 40: 35–41PubMedGoogle Scholar
  305. 305.
    Romoff MS, Keusch G, Campese VM, Wang M-S, Friedler RM, Weidmann P, Massry SG (1978) Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab 48: 26–31Google Scholar
  306. 306.
    Rose RJ, Miller JZ, Grim CE, Christian JC, Cardwell GF, Weinberger MH (1978) Aggregation of blood pressure in families of identical twins (abstr 47 ). Annual conference on cardiovascular disease epidemiology, Orlando, FloridaGoogle Scholar
  307. 307.
    Rosenthal J, Escobar-Jimenez F, Raptis S (1977) Prevention by somatostatin of rise in blood pressure and plasma renin mediated by beta-receptor stimulation. Clin Endocrinol 6: 455–462Google Scholar
  308. 308.
    Rosenthal J, Raptis S, Zoupas C, Escobar-Jiminez F (1978) Hemodynamic and renin responses to somatostatin in essential hypertension. Metabolism 27 (Suppl I): 1361–1363PubMedGoogle Scholar
  309. 309.
    Safar ME, Weiss YA, Leverson JA, London GM, Milliez PL (1973) Hemodynamic study of 85 patients with borderline hypertension. Am J Cardiol 31: 315–319PubMedGoogle Scholar
  310. 310.
    Safar ME, London GM, Weiss YA, Milliez PL (1975) Vascular reactivity in norepinephrine and hemodynamic parameters in borderline hypertension. Am Heart J 89: 480–486PubMedGoogle Scholar
  311. 311.
    Safar ME, London GM, Weiss YA, Miliez PL (1976) Neurogenic hyperactivity in borderline hypertension. In: Rorive G (ed) The arterial hypertensive disease. Masson, New York, pp 251–254Google Scholar
  312. 312.
    Sambhi MP (1977) Activators and inhibitors of renin. Chap 6.8 In: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 202–210Google Scholar
  313. 313.
    Sambhi MP, Eggena P, Barrett JD, Tuck M, Weidman CE, Thananopavarn C (1975) A circulating renin activator in essential hypertension. Circ Res 36 and 37 (Suppl I): 28–37Google Scholar
  314. 314.
    Sannerstedt R (1966) Hemodynamic response to exercise in patients with arterial hypertension. Acta Med Scand 180 (Suppl 458):l–83Google Scholar
  315. 315.
    Sannerstedt R (1969) Hemodynamic findings at rest and during exercise in mild central hypertension. Am J Med Sei 258: 70–79Google Scholar
  316. 316.
    Satoh S, Zimmerman BG (1975) Influence of the renin-angiotensin system on the effect of prostaglandin synthesis inhibitors in the renal vasculature. Circ Res 36 and 37 (Suppl I): 89–96Google Scholar
  317. 317.
    Schalekamp MADH, Schalekamp-Kuyken MPA, Birkenhäger WH (1970) Abnormal renal haemodynamics and renin suppression in hypertensive patients. Clin Sei 38: 101–110Google Scholar
  318. 318.
    Schalekamp MADH, Birkenhäger WH, Zaal GA, Kolsters G (1977) Haemodynamic characteristics of low-renin hypertension. Clin Sei Mol Med 52: 405–412Google Scholar
  319. 319.
    Schroeder HA (1964) Cadmium hypertension in rats. Am J Physiol 207: 62–66PubMedGoogle Scholar
  320. 320.
    Sen S, Smeby RR, Bumpus FM (1967) Isolation of a phospholipid renin inhibitor from the kidney. Biochemistry 6: 1572–1581PubMedGoogle Scholar
  321. 321.
    Sever PS (1978) Catecholamines in essential hyper-tension: the present controversy. In: Birkenhäger WH, Falke HE (eds) Circulating catecholamines and blood pressure. Bunge Scientific Publications, Utrecht, pp 1–10Google Scholar
  322. 322.
    Sever PS, Osikowska B, Birch M, Tunbridge RDG (1977) Plasma-noradrenaline in essential hypertension. Lancet 1: 1078–1081PubMedGoogle Scholar
  323. 323.
    Severs WB, Summy-Long J, Daniels-Sever A (1974) Angiotensin interaction with thirst mechanisms. Am J Physiol 226: 340–344PubMedGoogle Scholar
  324. 324.
    Shepherd JT, Vanhoutte PM (1979) The human cardiovascular system—facts and concepts. Raven Press, New York, p 210Google Scholar
  325. 325.
    Silbergeld EK, Chisolm JJ Jr (1976) Lead poisoning: altered urinary catecholamine metabolites as indicators of intoxication in mice and children. Science 192: 153–155PubMedGoogle Scholar
  326. 326.
    Slack BL, Ledingham JM (1976) The influence of sodium intake on the pressor response to angiotensin II in the unanesthetized rat. Clin Sei Mol Med 50: 285–291Google Scholar
  327. 327.
    Sleight P (1975) Baroreeeptor function in hypertension. In: Berglund C, Hanson L, Werko L (eds) Pathophysiology and management of arterial hypertension. Lindgren A and Sonner AB, Molndal, Sweden, pp 45–53Google Scholar
  328. 328.
    Smeby RR, Sen S, Rumpus FM (1967) A naturally occurring renin inhibitor. Circ Res 20 and 21 (Suppl II): 129–134Google Scholar
  329. 329.
    Stein OC, Hepner R, Greenstreet R (1975) Correlation of blood pressure with skinfold thickness and protein levels. Am J Dis Child 129: 905–911Google Scholar
  330. 330.
    Stoobandt R, Fagard R, Amery AKPC (1973) Are patients with essential hypertension and low renin protected against stroke and heart attack? Am Heart J 86: 781–787Google Scholar
  331. 331.
    Susie D, Sparks JC, Machado EA, Rentera D (1978) The mechanism of renomedullary antihypertensive action: haemodynamic studies in hydronephrotic rats with one-kidney renal-clip hypertension. Clin Sci Mol Med 54: 361–367Google Scholar
  332. 332.
    Swales JD (1975) Low-renin hypertension: nephrosclerosis? Lancet 1: 75–77PubMedGoogle Scholar
  333. 333.
    Syme SL, Oakes TW, Friedman GD, Feldman R, Siegelaub AB, Collen M (1974) Social class and racial differences in blood pressure. Am J Public Health 64: 619–620PubMedGoogle Scholar
  334. 334.
    Takahashi E, Sasake N, Takeda J, Ito H (1957) The geographic distribution of cerebral hemorrhage and hypertension in Japan. Hum Biol 29: 139–166PubMedGoogle Scholar
  335. 335.
    Takeshita A, Tanaka S, Kuroiwa A, Nakamura M (1975) Reduced baroreceptor sensitivity in borderline hypertension. Circulation 51: 738–742PubMedGoogle Scholar
  336. 336.
    Tan SY, Mulrow PJ (1977) Impaired renal prostaglandin E production: a newly identified lesion in hypertensives. Clin Res 25 (abstr): 450AGoogle Scholar
  337. 337.
    Tarazi RC (1976) Hemodynamic role of extracellular fluid in hypertension. Circ Res 38 (Suppl II): 73–83PubMedGoogle Scholar
  338. 338.
    Tarazi RC, Ibrahim MM, Dustan HP, Ferrario CM (1974) Cardiac factors in hypertension. Circ Res 34 (Suppl I): 213–221Google Scholar
  339. 339.
    Taylor AA, Pool JL, Lake CR, Ziegler MG, Rosen RA, Rollins DE, Mitchell JR (1978) Plasma norepinephrine concentrations: no differences among nor-mal volunteers and low, high, or normal renin hypertensive patients. Life Sci 22: 1499–1510PubMedGoogle Scholar
  340. 340.
    Terragno DA, Crowshaw K, Terragno NA, McGiff JC (1975) Prostaglandin synthesis by bovine mesenteric arteries and veins. Circ Res 36 and 37 (Suppl I): 76–80Google Scholar
  341. 341.
    Thind GS, Fischer GM (1976) Plasma cadmium and zinc in human hypertension. Clin Sci Mol Med 51: 483–486PubMedGoogle Scholar
  342. 342.
    Thomas CB (1952) The heritage of hypertension. Am J Med Sci 224: 367–376PubMedGoogle Scholar
  343. 343.
    Tibblin G, Aurell E, Paulin S, Sanne H (1967) High blood pressure and hypertensive disease in men born in 1913. In: Stamler J, Stamler R, Pullman TN (eds) The epidemiology of hypertension. Grune and Stratton, New York, pp 418–429Google Scholar
  344. 344.
    Tobian L (1978) Salt and hypertension. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sci 304: 178–202Google Scholar
  345. 345.
    Tobian L, Azar S (1971) Antihypertensive and other functions of the renal papilla. Trans Assoc Am Physicians 84: 281–288PubMedGoogle Scholar
  346. 346.
    Tobian L, Binion J (1954) Artery wall electrolytes in renal and DC A hypertension. J Clin Invest 33: 1407–1414PubMedGoogle Scholar
  347. 347.
    Tobian L, O’Donnell M (1976) Renal prostaglandins in relation to sodium regulation and hypertension. Fed Proc 35: 2388–2392PubMedGoogle Scholar
  348. 348.
    Turino PM, Manger WM, Webb KB, Hülse MC, Sussman RG, Forsyth ML, Campbell JP (1980) Effect of NaCl diet on blood pressure and tissue sodium and potassium in spontaneously hypertensive and normotensive rats (abstr 4837). Fed Proc 39: 1188Google Scholar
  349. 349.
    Vander AJ (1965) Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol 209: 659–662PubMedGoogle Scholar
  350. 350.
    Vane JR, McGiff JC (1975) Possible contributions of endogenous prostaglandins to the control of blood pressure. Circ Res 36 and 37 (Suppl I): 68–75Google Scholar
  351. 351.
    Vinci J, Zusman R, Bowden R, Horwitz D, Reiser H (1977) Relationship of urinary and plasma kinins to sodium-retaining steroids and plasma renin activity (abstr). Clin Res 25: 450AGoogle Scholar
  352. 352.
    Walker WG, Whelton PR, Saito H, Russell RP, Hermann J (1979) Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1: 287–291PubMedGoogle Scholar
  353. 353.
    Watkin DM, Froeb HF, Hatch FT, Gutman AB (1950) Effects of diet in essential hypertension. II. Results with unmodified Rempner rice diet in fifty hospitalized patients. Am J Med 9: 441–493PubMedGoogle Scholar
  354. 354.
    Webster ME (1970) Rallikreins in glandular tissues. Chap 3 In: Erdös, EG (ed) Handbook of experimental pharmacology, vol XXV. Bradykinin, kallidin and kallikrein. Springer-Verlag, New York, pl31Google Scholar
  355. 355.
    Weidmann P, Hirsch D, Berett-Piccoli C, Reubi FC, Ziegler WH (1977) Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am J Med 62: 209–218PubMedGoogle Scholar
  356. 356.
    Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH (1973) Serum dopamine-β-hydroxylase activity: sibling-sibling correlation. Science 181: 943–945PubMedGoogle Scholar
  357. 357.
    Werko L, Lagerlof H (1949) Studies on the circulation in man. IV. Cardiac output and blood pressure in the right auricle, right ventricle and pulmonary artery in patients with hypertensive cardiovascular disease. Acta Med Scand 133: 427–436PubMedGoogle Scholar
  358. 358.
    Werning C, Fischer N, Raip E, Stiel D, Trübenstein GR, Vetter H (1972) Increased renin stimulation after orthostasis in labile or borderline hypertension. Dtsch Med Wochenschr 97: 1038–1039PubMedGoogle Scholar
  359. 359.
    Wetterberg L, Åberg H, Ross SB, Fröden Ö (1972) Plasma dopamine-β-hydroxylase activity in hypertension and various neuropsychiatric disorders. Scand J Clin Lab Invest 30: 283–289PubMedGoogle Scholar
  360. 360.
    Wheatley D, Baiter M, Levine J, Lipman R, Bauer ML, Bonato R (1975) Psychiatric aspects of hypertension. Brit J Psychiatry 127: 327–336Google Scholar
  361. 361.
    Winer N, Carter CH (1978) Plasma norepinephrine response to cold pressor stimulation in normotensive and hypertensive subjects. Clin Res 26: 55AGoogle Scholar
  362. 362.
    Wong PY, Talamo RC, Williams GH, Colman RW (1975) Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Inves 55: 691–698Google Scholar
  363. 363.
    Yeoman GD, Dustan HP, Tarazi RC, Bravo EL (1976) Hypertension, obesity and blood volume (abstr). Kidney Int 10: 538Google Scholar
  364. 364.
    Yoshinaga K, Sato T, Ishida N (1960) Studies on the role of noradrenaline in the pathogenesis of hypertension. Tohoku J Exp Med 72: 301–308PubMedGoogle Scholar
  365. 365.
    Zimmerman BG, Gomer SK, Liao JC (1972) Action of angiotension on vascular adrenergic nerve endings: facilitation of norepinephrine release. Fed Proc 31: 1344–1350PubMedGoogle Scholar
  366. 366.
    Zinner SH, Levy PS, Kass EH (1971) Familial aggregation of blood pressure in childhood. N Engl J Med 284: 401–404PubMedGoogle Scholar
  367. 367.
    Zinner SH, Martin LF, Sacks F, Rosner B, Kass EH (1974) A longitudinal study of blood pressure in childhood. Am J Epidemiol 100: 437–442PubMedGoogle Scholar
  368. 368.
    Zinner SH, Margolius HS, Rasner B, Keiser HR, Kass EH (1976) Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am J Epidemiol 104: 124–132PubMedGoogle Scholar
  369. 369.
    Zinner SH, Margolius HS, Rosner BR, Kass EH (1977) Does hypertension begin in childhood? Studies on the familial aggregation of blood pressure in childhood. In: New MI, Levine LS (eds) Juvenile hypertension. Raven Press, New York, pp 45–53Google Scholar
  370. 370.
    Zinner SH, Margolius HS, Rosner BR, Kass EH (1977) Eight year longitudinal study of blood pressure and urinary kallikrein in childhood (abstr). Res 25: 266AGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1982

Authors and Affiliations

  • W. M. Manger
  • I. H. Page

There are no affiliations available

Personalised recommendations